No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / FL

Tryten Announces the Virtual Rounding Assistant-Tablet Cart to Support the Expansion of Efforts to Stop COVID-19

Editor: What To Know

  • Virtual rounding has surfaced as an important tool to bring care to patients safely and to workload balance across providers.
  • Tony Janzen, CEO and Founder of the company states, “Tryten is making every effort to bring effective, easy-to-deploy solutions to the market that can support our efforts to defeat COVID-19.
  • Curbside virtual care can move to stadiums, and temporary locations to expedite the delivery of vaccines and patient care.

Tryten notes COVID-19 is hitting record high infections, hospitalizations, and ICU bed occupancy reports

The company recently surpassed 500,000 deaths due to the virus. Hospitals and community health centers need solutions to rapidly meet the increasing demand for remote providers to safely access their patients. Healthcare delivery is moving into stadiums, temporary tents, and reconfigured hospital facilities.

Providers need access to many different locations to support vaccinations, testing, and delivery of care. Tablet-based virtual rounding can quickly bring remote experts to the point of care to safely leverage expertise across different locations. Curbside virtual care can move to stadiums, and temporary locations to expedite the delivery of vaccines and patient care.

Tryten’s Virtual Rounding Assistant-Tablet Cart is lightweight, easy to position and install. It supports BYO tablet and video. It is easily incorporated into current IT architectures. The elegant design includes cable management, an easy-to-position articulating arm, and various secure tablet mounts to enable rotation and tilt of the tablet. Tryten partners are available to provide the total solution including tablet, video, and services.

“Many have turned to virtual care to provide safe ways to leverage their resources. Virtual rounding has surfaced as an important tool to bring care to patients safely and to workload balance across providers. Tryten’s Virtual Rounding Assistant -Tablet Cart enables healthcare organizations to quickly mobilize their tablets and video telehealth tools. It can be deployed to support vaccination, triage, and testing. Nurses can use it as they collect vitals or doctors can use it for telehealth and rounding. We are determined to do our part to fight the virus and help those on the frontlines,” said Dr. Deborah Jeffries, Global Director of Healthcare for Tryten.

Tony Janzen, CEO and Founder of the company states, “Tryten is making every effort to bring effective, easy-to-deploy solutions to the market that can support our efforts to defeat COVID-19. Our entire team is focused on ways we can make a difference.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy